Investors Urged to Contact Hagens Berman in Erasca Lawsuit
Law firm Hagens Berman is investigating claims of securities law violations against Erasca, Inc. Investors must submit applications by August 10, 2026.
Hagens Berman, a national shareholder rights firm, is investigating claims in a class action lawsuit alleging securities law violations at Erasca, Inc. (NASDAQ: ERAS). The litigation alleges that Erasca and its senior executives misled investors by providing false or misleading information regarding the company's business and future prospects.
The lawsuit concerns Erasca's development of cancer therapies. Investors who purchased Erasca stock during a specific period are urged to contact Hagens Berman attorney Reed Kathrein before the July 30, 2026 deadline to apply for inclusion in the lawsuit. The exact class period will be determined during the litigation.
Hagens Berman is requesting that investors who believe they have suffered losses due to the decline in Erasca's stock value complete a questionnaire on the firm's website. The firm is gathering information from potential class members to pursue claims on their behalf.
The case is in its early stages. Company representatives have not yet responded to requests for comment. The class action seeks to recover damages for all investors who were allegedly misled.